Company / Capital Expenditures
ADC Therapeutics SA Capital Expenditures History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$264.0K
FY2025
5-year range
$264.0K / $3.2M
FY2023-FY2025
Trend
-91.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $687,000 to $264,000 over the past 2 years.
Based on SEC 10-K filings.
$264,000 in FY2025.
Declined from $687,000 to $264,000 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, capital expenditures decreased 91.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score -4.83 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $264.0K | -91.8% |
| FY2024 | $3.2M | +368.1% |
| FY2023 | $687.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026